APELLIS PHARMACEUTICALS INC's ticker is and the CUSIP is 03753U906. A total of 6 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,161,652 | +172.3% | 556,300 | +552.2% | 0.00% | +100.0% |
| Q2 2023 | $7,770,830 | -67.7% | 85,300 | -76.6% | 0.00% | -66.7% |
| Q1 2023 | $24,056,000 | +11621156.0% | 364,700 | +9017.5% | 0.00% | – |
| Q4 2022 | $207 | -100.0% | 4,000 | -94.5% | 0.00% | -100.0% |
| Q3 2022 | $4,952,000 | -41.1% | 72,500 | -56.2% | 0.00% | 0.0% |
| Q1 2022 | $8,409,000 | +125.6% | 165,500 | +46.3% | 0.00% | – |
| Q3 2021 | $3,728,000 | +98.6% | 113,100 | +280.8% | 0.00% | – |
| Q2 2021 | $1,877,000 | +709.1% | 29,700 | +450.0% | 0.00% | – |
| Q1 2021 | $232,000 | -96.3% | 5,400 | -97.4% | 0.00% | -100.0% |
| Q4 2019 | $6,323,000 | – | 206,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 300,000 | $9,888,000 | 2.91% |
| PURA VIDA INVESTMENTS, LLC | 259,100 | $8,540,000 | 0.26% |
| GROUP ONE TRADING, L.P. | 92,000 | $3,032,000 | 0.00% |
| SIMPLEX TRADING, LLC | 17,400 | $1,179,000 | 0.00% |
| JPMORGAN CHASE & CO | 113,100 | $3,728,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |